Literature DB >> 22136493

Inhibitory activities of baicalin against renin and angiotensin-converting enzyme.

Y F Deng1, R E Aluko, Q Jin, Y Zhang, L J Yuan.   

Abstract

CONTEXT: Baicalin has been characterized as the active compound and quality control marker in Scutellaria baicalensis Georgi, traditionally used as a hypotensive herb.
OBJECTIVES: To investigate the inhibitory activities of baicalin against renin and angiotensin-I converting enzyme (ACE) and their molecule mechanism of interactions.
METHODS: The fluorescence method using renin substrate 1(R-2932) and the spectroscopy method by Cushman were used to determine renin and ACE activities, respectively. The fluorescence quench techniques were used to characterize their interactions.
RESULTS: The results showed that baicalin inhibited renin activity with an IC(50) value of 120.36 µM and inhibited ACE activity with an IC(50) value of 2.24 mM in vitro. The fluorescence emission of both renin and ACE were efficiently quenched by baicalin and a complete quenching was achieved at a high concentration of baicalin. Furthermore, baicalin was more effective in quenching the fluorescence of renin (K(SV) = 60 × 10(3) M(-1)) than ACE (K(SV) = 17.1 × 10(3) M(-1)). The quenching of fluorescence of renin and ACE involved static interactions, which was characterized by the formation of quencher-enzyme complex. The baicalin-renin complex formed through three-sites binding including the active site with a binding constant of 796.15 × 10(13) M(-1), but there was only one binding site for the baicalin-ACE complex with a much smaller binding constant of 6.8 × 10(5) M(-1).
CONCLUSION: The inhibition activity of baicalin against renin was a result of the formation of stable complex through multisites binding including the active site, which could explain the higher inhibitory efficiency.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22136493     DOI: 10.3109/13880209.2011.608076

Source DB:  PubMed          Journal:  Pharm Biol        ISSN: 1388-0209            Impact factor:   3.503


  18 in total

1.  The effect of baicalin in a mouse model of retinopathy of prematurity.

Authors:  Hyoung Jo; Sang Hoon Jung; Hye Bin Yim; Sung Jin Lee; Kui Dong Kang
Journal:  BMB Rep       Date:  2015-05       Impact factor: 4.778

2.  Protective effects of Scutellaria baicalensis Georgi against hydrogen peroxide-induced DNA damage and apoptosis in HaCaT human skin keratinocytes.

Authors:  Jung Jeh Yoon; Jin-Woo Jeong; Eun Ok Choi; Min Ju Kim; Hyun Hwang-Bo; Hong Jae Kim; Su Hyun Hong; Cheol Park; Dong Hee Lee; Yung Hyun Choi
Journal:  EXCLI J       Date:  2017-03-31       Impact factor: 4.068

Review 3.  Current Findings Regarding Natural Components With Potential Anti-2019-nCoV Activity.

Authors:  Jin Zhou; Jie Huang
Journal:  Front Cell Dev Biol       Date:  2020-07-03

4.  Potentials of plant-based substance to inhabit and probable cure for the COVID-19.

Authors:  Israt Jahan; Ahmet Onay
Journal:  Turk J Biol       Date:  2020-06-21

Review 5.  Natural Flavonoids as Potential Angiotensin-Converting Enzyme 2 Inhibitors for Anti-SARS-CoV-2.

Authors:  Muchtaridi Muchtaridi; M Fauzi; Nur Kusaira Khairul Ikram; Amirah Mohd Gazzali; Habibah A Wahab
Journal:  Molecules       Date:  2020-09-01       Impact factor: 4.411

6.  Kinetics and mechanism study of competitive inhibition of jack-bean urease by baicalin.

Authors:  Lirong Tan; Jiyan Su; Dianwei Wu; Xiaodan Yu; Zuqing Su; Jingjin He; Xiaoli Wu; Songzhi Kong; Xiaoping Lai; Ji Lin; Ziren Su
Journal:  ScientificWorldJournal       Date:  2013-10-01

Review 7.  An overview on COVID-19: reality and expectation.

Authors:  Manal A Hamed
Journal:  Bull Natl Res Cent       Date:  2020-06-01

Review 8.  Traditional Chinese Medicine in the Treatment of Patients Infected with 2019-New Coronavirus (SARS-CoV-2): A Review and Perspective.

Authors:  Yang Yang; Md Sahidul Islam; Jin Wang; Yuan Li; Xin Chen
Journal:  Int J Biol Sci       Date:  2020-03-15       Impact factor: 6.580

9.  Nanoparticle-Mediated Dual Targeting: An Approach for Enhanced Baicalin Delivery to the Liver.

Authors:  Iman Saad Ahmed; Hassan Medhat Rashed; Hend Fayez; Faten Farouk; Rehab Nabil Shamma
Journal:  Pharmaceutics       Date:  2020-01-29       Impact factor: 6.321

Review 10.  Comprehensive review on the prevailing COVID-19 therapeutics and the potential of repurposing SARS-CoV-1 candidate drugs to target SARS-CoV-2 as a fast-track treatment and prevention option.

Authors:  Shanthi Sabarimurugan; Arun Dharmarajan; Sudha Warrier; Maheswari Subramanian; Rajarajan Swaminathan
Journal:  Ann Transl Med       Date:  2020-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.